Societal CDMO Inc (DELISTED) (SCTL:DL)
1.10
0.00 (0.00%)
USD |
NASDAQ |
Apr 08, 16:00
Societal CDMO Free Cash Flow: -9.242M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -9.242M |
| September 30, 2023 | -10.78M |
| June 30, 2023 | -9.723M |
| March 31, 2023 | -8.436M |
| December 31, 2022 | -12.00M |
| September 30, 2022 | -9.334M |
| June 30, 2022 | -4.471M |
| March 31, 2022 | -2.653M |
| December 31, 2021 | 5.569M |
| September 30, 2021 | 4.337M |
| June 30, 2021 | 0.092M |
| March 31, 2021 | -2.848M |
| December 31, 2020 | 0.464M |
| September 30, 2020 | -3.036M |
| June 30, 2020 | 2.405M |
| March 31, 2020 | -16.95M |
| December 31, 2019 | -33.84M |
| September 30, 2019 | -41.83M |
| June 30, 2019 | -58.31M |
| March 31, 2019 | -49.00M |
| December 31, 2018 | -50.31M |
| Date | Value |
|---|---|
| September 30, 2018 | -38.89M |
| June 30, 2018 | -35.52M |
| March 31, 2018 | -30.02M |
| December 31, 2017 | -22.45M |
| September 30, 2017 | -23.82M |
| June 30, 2017 | -14.68M |
| March 31, 2017 | -13.06M |
| December 31, 2016 | -6.972M |
| September 30, 2016 | -6.217M |
| June 30, 2016 | -0.932M |
| March 31, 2016 | 6.225M |
| December 31, 2015 | 8.458M |
| September 30, 2015 | 3.62M |
| June 30, 2015 | -6.447M |
| March 31, 2015 | -13.02M |
| December 31, 2014 | -10.87M |
| September 30, 2014 | -6.796M |
| June 30, 2014 | -3.140M |
| March 31, 2014 | -1.582M |
| December 31, 2013 | -0.8166M |
Free Cash Flow Range, Past 5 Years
-58.31M
Minimum
Jun 2019
5.569M
Maximum
Dec 2021
-11.08M
Average
-8.436M
Median
Mar 2023
Free Cash Flow Benchmarks
| XOMA Corp | -18.20M |
| Ironwood Pharmaceuticals Inc | 147.91M |
| CymaBay Therapeutics Inc (DELISTED) | -72.98M |
| Homology Medicines Inc (DELISTED) | -96.46M |
| Amgen Inc | 7.098B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 1.527M |
| Cash from Investing (Quarterly) | -0.734M |
| Cash from Financing (Quarterly) | -0.854M |
| Free Cash Flow Per Share (Quarterly) | 0.0076 |
| Free Cash Flow to Equity (Quarterly) | 1.033M |
| Free Cash Flow to Firm (Quarterly) | 3.37M |
| Free Cash Flow Yield | -8.90% |